I can't even believe that I am entertaining the notion of getting involved in a conversation with an aggie of how people with academic doctorates refer to themselves in real life situations compared to physician's use of the term doctor.
Not really, outside academic settings.
The best clowns are the ones that have them in their social media handles though. Surly weather man not included of course.
We should have totally different set of physical and mental health screening guidance for potus compared to my elderly uncle. The risk dynamic around false positives is totally different. It’s not a population health equation at that level. Well it is. But a very different one.
I all seriousness, I think their drug has big potential upside. The fda really fucked them full fist. Not sure the regulatory environment esp wrt oncology is going to be rosy in the near term future. Price target $25.
It's almost like any other psychiatric condition should be handled, informed by the principles of evidence based medicine.
It's wilding that this is not obvious.
Maybe read it this time.
I know yall will hate this one. I could post the euro reviews, and we'll hear about TERF island or other dumb shit, but here you go. Economist piece posted as well as AAP for full balance (still waiting on their systematic review, lol).
https://opa.hhs.gov/sites/default/files/2025-05/gender-dysphoria-report.pdf
The economist treatment: https://www.economist.com/united-states/2025/05/05/where-the-trump-administration-has-science-on-its-side
And for good measure to get in front of it, the AAP response, which is lol: https://publications.aap.org/aapnews/news/32145/AAP-speaks-out-against-HHS-report-on-gender
Seems otherwise.
None of you had a problem with the principles of evidence based medicine when it was directed at ivermectin and HCQ and clowns like triple horn. Sorry if you find yourself on the other end of that equation now and find it uncomfortable.